Experience
Secured Motion to Dismiss in Illinois Consumer Fraud and Deceptive Business Practices Act Case
Secured motion to dismiss with prejudice in Cook County Chancery Court for the client, a pharmaceutical company, in an action brought by the Illinois Attorney General against various manufacturers and distributors. The plaintiff alleged that the defendants had created a public nuisance and violated the Illinois Consumer Fraud and Deceptive Business Practices Act, and that the distributors had failed to properly examine and report suspicious orders of opioid medications.
Favorable Settlement in Multimillion-Dollar Wrongful Death Claim
Obtained a favorable settlement in Jackson County, Missouri, in a wrongful death case seeking punitive damages involving allegations of failure to timely treat bowel perforation.
Developer Representation in Hospital Site Purchase
Represented the developer in the sale of a site to a Missouri health care system for the construction of a hospital.
Issuer Counsel to Health Care/Fintech Emerging Company
Negotiated multimillion-dollar Series Seed funding round for Missouri company with health care and financial technology product. Investors included leading venture capital firms from Chicago and St. Louis.
Advised Dentist in Sale of Local Practice
Assisted in the representation of a dentist in the sale of a local practice.
Multimillion-Dollar Sale of Local Veterinary Practice to National Provider
Assisted in the representation of a veterinarian in the multimillion-dollar sale of the local practice to a national provider, including the negotiation of future employment terms.
Summary Judgment for Biopharmaceutical Company on Wage Law Claim
Represented biopharmaceutical client in defending against complaint by former employee alleging violation of Massachusetts Wage Act and breach of contract. Briefed and argued motion for summary judgment, resulting in judgment for client on all counts.
Multimillion-Dollar Venture Capital Investment into Biotech Company
Advised lead investor on multimillion-dollar Series A venture capital investment into biotech company developing and commercializing cutting-edge technologies for gene editing, gene expression and bioprocessing.
Successfully Secured Photo Usage Rights for Animal Care Client
Drafted and successfully secured releases for the authorized use of third-party photographs in animal care client’s marketing and advertising campaigns.
Summary Judgment for Health Care Client in Federal Trademark Infringement Suit
Secured summary judgment on behalf of the defendant, one of the largest non-profit hospital systems in the country, in a trademark infringement suit in federal court. The successful defense ensured the continued use of a naming convention impacting more than 25 health care delivery locations across the Midwest.
Patent Portfolio Strategy for University Covering Science, Engineering and Medical Fields
Developed and executed patent filing strategy and managed diverse patent portfolio for a large university client. Technologies span various subject areas including science, engineering and medical fields.
Contract Negotiations for Multimillion-Dollar Hospital Development
Represented a large general contractor in the preparation and negotiation of AIA contract documents for a multimillion-dollar hospital development in Illinois.
Licensing and Manufacturing Agreements for Animal Health Company
Advised a company developing animal vaccines in connection with obtaining a license for technology to be used in the manufacture of its products and negotiating manufacturing and research agreements.
Managed Construction Defects Dispute for Assisted Living Center
Represented a large general contractor in a dispute with the owner and multiple levels of subcontractors concerning subcontractor construction defects in an assisted living center in Georgia.
Management of U.S. and Foreign Patent Families for Major Medical Device Companies
Managed multiple U.S. and foreign patent families and provided strategic counsel for medical device companies involving technologies related to fluorescent imaging, vascular occlusion, neuromodulation, and renal and cardiovascular devices.
Portfolio Management, Strategic Direction for Multiple Consumer Products, Health Care Companies
Managed global patent portfolios for and provided strategic counsel to multimillion-dollar consumer products and health care companies in the U.S. and abroad, including preparation and prosecution, opinion work, Inter Partes Review work and litigation.
Defense Verdict in Case Involving Rare Neurological Disorder
Found and retained an expert witness after extensive research to address a rare neurological disorder, resulting in a defense verdict.
Defense Verdict in Heavy Metal Poisoning Case
Found, retained and prepared an expert witness for trial, who addressed heavy metal poisoning in a neonate, resulting in a defense verdict.
Summary Judgment in Qui Tam Action Alleging Medicare Fraud
Obtained summary judgment on behalf of health care client in a qui tam action under the False Claims Act. In this case, the whistle blower sought over $1 billion, based on all claims submitted. The judgment, regarding allegation of Medicare fraud, was successfully defended on appeal.
Licensing, Lien Waiver and Contract Assistance for National Community of Retirement Facilities
On behalf of a Denver-based leading developer, owner and operator of retirement, assisted living and memory care communities across the United States, assisted in business licensing, drafting lien waivers and reviewing employment requirements for assisted living facilities, and drafted business contracts.
Defense Verdict in Case Involving Loss of Eyesight
Served as co-counsel in a case involving loss of eyesight, resulting in a defense verdict.
IP Due Diligence in $3.4 Billion Acquisition of Medical Device Manufacturer
Led IP due diligence for a major medical device company, including in-depth research and analysis of both the target company and its competitors, resulting in our client’s decision to move ahead with its $3.4 billion acquisition of a medical device manufacturer.
Successfully Resolved a Case Involving Serious Neurological Injuries
Assisted in successfully resolving a case involving serious neurological injuries related to a stroke.
$32 Million Merger Acquisition of Health Care Tech and Services Provider
Represented health care company in $32 million merger acquisition of health care technology and services provider, following the client’s prior convertible debt investment in the target company.
Acquisitions in Health Care Field for Private Equity Fund
Represented a private equity fund in nine acquisitions of health care accounts receivables management and Medicaid eligibility companies with locations nationwide. These acquisitions involved related credit facility negotiations. As a result of these acquisitions, the private equity fund was able to achieve its roll-up strategy in the industry.
Dismissal for Physician in Personal Injury Case
Won an order dismissing a physician for lack of personal jurisdiction in U.S. District Court for the Southern District of Illinois in an action for injuries related to cosmetic laser surgery.
Obtained Consent Injunction for Health Care Organization in Trade Secret Case
Obtained consent injunction against former executives of a large health care organization and competitor in the U.S. District Court for the Southern District of Ohio, enforcing noncompetition and nonsolicitation provisions and requiring return and destruction of documents.
Pharmaceutical Product Name Clearance Advice
Reported on the availability for use and registration of proposed pharmaceutical product name for a leading U.K. generics manufacturer on a time sensitive basis in order to gain MHRA approval.
Counsel to LAVA Therapeutics in Multimillion-Dollar Global License Agreement
Served as IP counsel to client LAVA Therapeutics, a clinical-stage immuno-oncology company, in a multimillion-dollar global license agreement with Seagen, Inc., a world leader and pioneer in antibody-drug conjugate (ADC) therapies. The exclusive license agreement will enable Seagen to develop, manufacture and commercialize LAVA-1223, an advanced preclinical asset that utilizes LAVA’s proprietary Gammabody™ technology to target epidermal growth factor receptor (EGFR)-expressing solid tumors, most commonly associated with colorectal, lung, head and neck cancer.
Representation of SaaS Company
Advised cloud-based SaaS company in connection with various master services agreements, statements of work, information security agreements and business associate agreements with its insurance company customers.
- Page 2 of 5